Kezar Life Sciences Inc (NASDAQ:KZR)
| 1.16 Delayed Data As of Sep 27 |  +0.07 / +6.48%Today’s Change | 1.08 Today|||52-Week Range 9.00 | -83.59% Year-to-Date |
Latest KZR News | Press Releases
No recent news for Kezar Life Sciences Inc.
Today’s Trading
| Previous close | 1.08 |
| Today’s open | 1.10 |
| Day’s range | 1.10 - 1.16 |
| Volume | 308,123 |
| Average volume (3 months) | 624,055 |
| Market cap | $82.9M |
Data as of 3:59pm ET, 09/27/2023
Growth & Valuation
| Earnings growth (last year) | +2.18% |
| Earnings growth (this year) | -29.04% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.29 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SYRSSyros Pharmaceutical... | +0.06 | +1.53% |
| NGMNGM Biopharmaceutica... | 0.00 | 0.00% |
| CSBRChampions Oncology I... | +0.13 | +2.30% |
| CGENCompugen Ltd | -0.03 | -3.46% |
Data as of 3:59pm ET, 09/27/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$68.2M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
